-
2
-
-
73149105939
-
Management of stage I seminomatous testicular cancer: a systematic review
-
Chung P, Mayhew LA, Warde P et al. Management of stage I seminomatous testicular cancer: a systematic review. Clin Oncol (R Coll Radiol) 2010; 22: 6-16.
-
(2010)
Clin Oncol (R Coll Radiol)
, vol.22
, pp. 6-16
-
-
Chung, P.1
Mayhew, L.A.2
Warde, P.3
-
3
-
-
77954866764
-
Management options for stage I seminoma
-
Aparicio J, Díaz R. Management options for stage I seminoma. Expert Rev Anticancer Ther 2010; 10: 1077-1085.
-
(2010)
Expert Rev Anticancer Ther
, vol.10
, pp. 1077-1085
-
-
Aparicio, J.1
Díaz, R.2
-
4
-
-
0037112184
-
Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis
-
Warde P, Specht L, Horwich A et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002; 20: 4448-4452.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4448-4452
-
-
Warde, P.1
Specht, L.2
Horwich, A.3
-
5
-
-
0038012184
-
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
-
Aparicio J, García del Muro X, Maroto P et al. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol 2003; 14: 867-872.
-
(2003)
Ann Oncol
, vol.14
, pp. 867-872
-
-
Aparicio, J.1
García del Muro, X.2
Maroto, P.3
-
6
-
-
33644660123
-
Risk-adapted management for patients with clinical stage I seminoma: the second Spanish Germ Cell Cancer Group study
-
Aparicio J, Germa JR, García del Muro X et al. Risk-adapted management for patients with clinical stage I seminoma: the second Spanish Germ Cell Cancer Group study. J Clin Oncol 2005; 23: 8717-8723.
-
(2005)
J Clin Oncol
, vol.23
, pp. 8717-8723
-
-
Aparicio, J.1
Germa, J.R.2
García del Muro, X.3
-
7
-
-
83355169744
-
Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study
-
Aparicio J, Maroto P, García del Muro X et al. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study. J Clin Oncol 2011; 29: 4677-4681.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4677-4681
-
-
Aparicio, J.1
Maroto, P.2
García del Muro, X.3
-
8
-
-
84875591927
-
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
-
Beyer J, Albers P, Altena R et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 2013; 24: 878-888.
-
(2013)
Ann Oncol
, vol.24
, pp. 878-888
-
-
Beyer, J.1
Albers, P.2
Altena, R.3
-
9
-
-
79952082270
-
Prognostic factors for relapse in stage I seminoma managed with surveillance: a validation study
-
Chung PW, Daugaard G, Tydlesley S et al. Prognostic factors for relapse in stage I seminoma managed with surveillance: a validation study. J Clin Oncol 2010; 28 (15s): abstr 4535.
-
(2010)
J Clin Oncol
, vol.28
, Issue.15
-
-
Chung, P.W.1
Daugaard, G.2
Tydlesley, S.3
-
10
-
-
79952094417
-
Management of seminomatous testicular cancer: a binational prospective population-bases study from the Swedish Norwegian testicular cancer study group
-
Tandstad T, Smaaland R, Solberg A et al. Management of seminomatous testicular cancer: a binational prospective population-bases study from the Swedish Norwegian testicular cancer study group. J Clin Oncol 2011; 29: 719-725.
-
(2011)
J Clin Oncol
, vol.29
, pp. 719-725
-
-
Tandstad, T.1
Smaaland, R.2
Solberg, A.3
-
11
-
-
56749175245
-
Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study
-
Garcia-del-Muro X, Maroto P, Gumà J et al. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study. J Clin Oncol 2008; 26: 5416-5421.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5416-5421
-
-
Garcia-del-Muro, X.1
Maroto, P.2
Gumà, J.3
-
12
-
-
79953324912
-
Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies
-
Kollmannsberger C, Tyldesley S, Moore C et al. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. Ann Oncol 2011; 22: 808-814.
-
(2011)
Ann Oncol
, vol.22
, pp. 808-814
-
-
Kollmannsberger, C.1
Tyldesley, S.2
Moore, C.3
-
13
-
-
84864445837
-
Patterns of care in the management of seminoma stage I: results from a European survey
-
Vossen CY, Horwich A, Daugaard G et al. Patterns of care in the management of seminoma stage I: results from a European survey. BJU Int 2012; 110: 524-531.
-
(2012)
BJU Int
, vol.110
, pp. 524-531
-
-
Vossen, C.Y.1
Horwich, A.2
Daugaard, G.3
-
14
-
-
84879617192
-
Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer
-
Grimison P, Houghton B, Chatfield M et al. Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU Int 2013; 112: E35-E43.
-
(2013)
BJU Int
, vol.112
, pp. E35-E43
-
-
Grimison, P.1
Houghton, B.2
Chatfield, M.3
-
15
-
-
84885481001
-
A nationwide cohort study of surveillance for stage I seminoma
-
Mortensen MS, Gundgaard MG, Lauritsen J et al. A nationwide cohort study of surveillance for stage I seminoma. J Clin Oncol 2013; 31(suppl); abstr 4502.
-
(2013)
J Clin Oncol
, vol.31
-
-
Mortensen, M.S.1
Gundgaard, M.G.2
Lauritsen, J.3
-
16
-
-
77954345456
-
Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
Schmoll HJ, Jordan K, Huddart R et al. Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (suppl 5): v140-v146.
-
(2010)
Ann Oncol
, vol.21
, pp. v140-v146
-
-
Schmoll, H.J.1
Jordan, K.2
Huddart, R.3
-
17
-
-
79959546636
-
EAU guidelines on testicular cancer: 2011 update
-
Albers P, Albrecht W, Algaba F et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011; 60: 304-319.
-
(2011)
Eur Urol
, vol.60
, pp. 304-319
-
-
Albers, P.1
Albrecht, W.2
Algaba, F.3
-
19
-
-
79952741548
-
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC30982 Study (ISRCTN27163214)
-
Oliver RTD, Mead GM, Rustin GJS et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC30982 Study (ISRCTN27163214). J Clin Oncol 2011; 29: 957-962.
-
(2011)
J Clin Oncol
, vol.29
, pp. 957-962
-
-
Oliver, R.T.D.1
Mead, G.M.2
Rustin, G.J.S.3
-
20
-
-
40149089203
-
The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis
-
Powles T, Robinson D, Shamash J et al. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 2008; 19: 443-447.
-
(2008)
Ann Oncol
, vol.19
, pp. 443-447
-
-
Powles, T.1
Robinson, D.2
Shamash, J.3
-
21
-
-
84905107175
-
Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma; clinical outcomes and prognostic factors for relapse in a large US cohort
-
Soper MS, Hastings JR, Cosmatos HA et al. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma; clinical outcomes and prognostic factors for relapse in a large US cohort. Am J Clin Oncol 2014; 37: 356-359.
-
(2014)
Am J Clin Oncol
, vol.37
, pp. 356-359
-
-
Soper, M.S.1
Hastings, J.R.2
Cosmatos, H.A.3
-
22
-
-
78649599450
-
Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients
-
Kamba T, Kamoto T, Okubo K et al. Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients. Int J Urol 2010; 17: 980-988.
-
(2010)
Int J Urol
, vol.17
, pp. 980-988
-
-
Kamba, T.1
Kamoto, T.2
Okubo, K.3
|